Eagle Pharmaceuticals, Inc.

NASDAQ:EGRX

4.31 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q3
Revenue 64.64666.30560.69965.90174.136115.87442.3239.85348.12441.24949.91649.92841.93846.0248.25841.14756.70249.78556.05451.33759.29646.62646.78563.02150.10876.79381.14137.83340.91829.59118.1815.7366.00236.3095.62.8115.7925.0055.4924.645.0752.4811.4831.306
Cost of Revenue 16.85817.319.86623.65123.66427.75512.3098.25910.75710.85512.54111.98613.1357.80311.59114.92221.28413.118.55712.99118.55911.80813.70711.66513.8217.99418.81910.42511.47314.5892.5983.7533.3485.9484.4892.1741.5563.364.6242.9312.9251.3130.2110.842
Gross Profit 47.78849.00540.83342.2550.47288.11930.01131.59437.36730.39437.37537.94228.80338.21736.66726.22535.41836.68537.49738.34640.73734.81833.07851.35636.28858.79962.32227.40829.44515.00215.5831.9832.65430.3611.1110.6374.2361.6450.8671.7082.151.1681.2720.464
Gross Profit Ratio 0.7390.7390.6730.6410.6810.760.7090.7930.7760.7370.7490.760.6870.830.760.6370.6250.7370.6690.7470.6870.7470.7070.8150.7240.7660.7680.7240.720.5070.8570.3460.4420.8360.1980.2270.7310.3290.1580.3680.4240.4710.8580.356
Reseach & Development Expenses 9.8339.2727.2179.32611.4376.1083.78723.2899.91114.2889.3954.8287.1359.42711.30610.1728.9576.3755.8595.97515.26517.329.4098.9546.6847.52516.653.2073.7296.6768.7826.9115.8786.2853.9865.8884.5453.7942.5893.421.6322.5252.2192.561
General & Administrative Expenses 23.25124.2620.7521.76235.03220.48213.12517.98216.23619.57917.68717.39717.15923.64221.73717.98116.73717.51514.78613.26914.86914.29815.00114.10114.9112.64211.4278.7898.7428.5694.7364.153.4993.0271.8712.6732.6731.12200.702-0.742000
Selling & Marketing Expenses 4.43.73.41.71.81.77.20.50.40.30.50.30.81.1130.7270.5560.4910.6260.690.6091.1180.895-1.652.5688.7925.9365.9593.1043.3182.4040.8721.311.6120.9591.821.1820.5960.33300.1180000
SG&A 27.65127.9624.1523.46236.83222.18220.32518.48216.63619.87918.18717.69717.95924.75522.46418.53717.22818.14115.47613.87815.98715.19313.35116.66923.70218.57817.38611.89312.0610.9735.6085.465.1113.9863.693.8552.6731.4541.3440.82-0.7422.9491.9311.821
Other Expenses 0.247-0.2385.501-7.916-7.763-1.957-4.445-2.284-5.0135.51.987-6.0492.3-6.50.712.13718.1759.55471.7688.7120.797.22358.6945.5988.9110.76553.55600015.6470000-0.0010.03500000.00300
Operating Expenses 37.48437.23231.36732.78848.26928.2924.11241.77126.54734.16727.58222.52525.09434.18233.7728.70926.18524.51621.33519.85331.25232.51322.7625.62330.38626.10334.03615.115.78917.64914.3912.37110.98910.2717.6769.7437.2195.2483.9334.240.895.4744.1494.434
Operating Income 10.3046.1879.466-2.3062.20359.8295.899-10.17710.82-3.7739.79315.4173.7094.0352.897-2.4849.23312.16915.7318.4020.1832.30510.44124.955.90232.69628.28612.30813.656-0.8971.193-10.388-8.33520.09-6.565-9.106-2.982-3.603-3.065-2.5311.26-4.306-2.877-3.918
Operating Income Ratio 0.1590.0930.156-0.0350.030.5160.139-0.2550.225-0.0910.1960.3090.0880.0880.06-0.060.1630.2440.2810.3580.0030.0490.2230.3960.1180.4260.3490.3250.334-0.030.066-1.811-1.3890.553-1.172-3.239-0.515-0.72-0.558-0.5460.248-1.736-1.94-3
Total Other Income Expenses Net 0.2474.0443.8382.261-7.763-2.169-4.445-2.284-5.0135.51.987-6.0492.3-6.50.7-0.058-0.028-0.192-0.432-0.091-9.302-0.6480.123-0.783-0.026-0.0240.0060.0230.0271.750.001-0.0030.0050.0060.212-00.035-0.382-0.1913.014-0.0150.003-0.356-0.375
Income Before Tax 9.29810.23113.304-0.045-5.86857.661.224-12.665.5481.3411.3878.9255.373-3.0083.358-2.5429.20511.97715.23417.668-0.5171.6579.93824.4585.87632.67228.29212.33113.683-0.8771.194-10.385-8.3320.096-6.565-9.104-2.934-3.979-3.2550.4830.755-4.804-3.381-4.293
Income Before Tax Ratio 0.1440.1540.219-0.001-0.0790.4980.029-0.3180.1150.0320.2280.1790.128-0.0650.07-0.0620.1620.2410.2720.344-0.0090.0360.2120.3880.1170.4250.3490.3260.334-0.030.066-1.81-1.3880.553-1.172-3.239-0.507-0.795-0.5930.1040.149-1.936-2.28-3.287
Income Tax Expense 4.1344.4815.1393.4683.58213.6027.42-7.0381.9361.7613.331.8665.629-0.1372.353-0.1522.483.0042.6443.628-3.176-0.9590.8549.0271.3739.748-29.0090.3790.5840.019-0.025-0.218-0.1530.399-1.059-00.04-1.295000.4530.475-0.8990.002
Net Income 5.1645.758.165-3.513-9.4544.058-6.196-5.6223.612-0.4218.0577.059-0.256-2.8711.005-2.396.7258.97312.5914.042.6592.6169.08515.4314.50322.92457.30111.95213.099-0.8961.219-10.167-8.17719.697-5.506-9.104-2.934-2.684-3.2550.4830.755-4.804-2.482-5.196
Net Income Ratio 0.080.0870.135-0.053-0.1270.38-0.146-0.1410.075-0.010.1610.141-0.006-0.0620.021-0.0580.1190.180.2250.2730.0450.0560.1940.2450.090.2990.7060.3160.32-0.030.067-1.772-1.3620.542-0.983-3.239-0.507-0.536-0.5930.1040.149-1.936-1.674-3.979
EPS 0.390.440.63-0.27-0.743.47-0.48-0.430.28-0.0320.60.52-0.019-0.210.07-0.170.490.640.880.940.180.180.611.030.31.53.750.770.84-0.060.08-0.65-0.531.38-0.39-0.65-0.21-0.3-0.230.0460.071-0.45-0.23-3.14
EPS Diluted 0.390.440.62-0.27-0.743.41-0.48-0.430.27-0.0320.590.51-0.019-0.210.07-0.170.480.620.860.910.170.170.580.980.281.423.520.730.8-0.0570.07-0.65-0.531.31-0.39-0.65-0.21-0.3-0.230.0460.071-0.45-0.23-3.14
EBITDA 10.74611.74715.2841.546-3.68258.9341.619-11.3616.8642.65812.93110.7857.285-0.9815.347-1.91411.00213.79616.28419.33710.4743.34310.35726.7056.86333.60728.29412.713.998-2.6261.196-10.371-8.31720.097-6.551-9.101-2.907-3.567-3.033-2.5011.249-4.306-2.853-3.864
EBITDA Ratio 0.1660.1770.2520.023-0.050.5090.038-0.2850.1430.0640.2590.2160.174-0.0210.111-0.0470.1940.2770.2910.3770.1770.0720.2210.4240.1370.4380.3490.3360.342-0.0890.066-1.808-1.3860.553-1.17-3.238-0.502-0.713-0.552-0.5390.246-1.736-1.924-2.958